Rate of Malignancy Low in Pediatric LM Rate of Malignancy Low in Pediatric LM
MedWorm - Melanoma News
by
1w ago
Pediatric longitudinal melanonychia may look like subungual melanoma in adults, but a low probability of malignancy makes clinical monitoring a reasonable noninvasive management strategy.Medscape Medical News (Source: Medscape Medical News Headlines ..read more
Visit website
Medicare IHC Claims With Melanoma Dxs Increased, Study Finds Medicare IHC Claims With Melanoma Dxs Increased, Study Finds
MedWorm - Melanoma News
by
1w ago
With sparse guidance regarding best practices for IHC in melanoma diagnosis, more research is needed to optimize use of IHC in this setting, according to the authors.MDedge News (Source: Medscape Hematology-Oncology Headlines ..read more
Visit website
Ninja, Video Gaming Star on Twitch, Reveals Skin Cancer Diagnosis
MedWorm - Melanoma News
by
2w ago
Tyler Blevins, the video game superstar known as Ninja, revealed this week that he had been diagnosed with melanoma, a form of skin cancer. Mr. Blevins, 32, said on social media on Tuesday that a mole was removed from his foot during an annual checkup with a dermatologist a few weeks ago. “It came…#tylerblevins #ninja (Source: Reuters: Health ..read more
Visit website
Antidote and Melanoma Research Alliance join forces to enhance clinical trial search for people impacted by melanoma
MedWorm - Melanoma News
by
3w ago
The collaboration introduces an improved patient and caregiver experience to facilitate more accurate matches to appropriate clinical trials for individuals affected by melanoma. MIAMI and WASHINGTON, March 26, 2024 /PRNewswire-PRWeb/ -- Antidote Technologies ("Antidote"), a... (Source: PRWeb: Medical Pharmaceuticals ..read more
Visit website
Ninja, Twitch ’s Top Streamer, Reveals Skin Cancer Diagnosis
MedWorm - Melanoma News
by
3w ago
The gamer, Tyler Blevins, said a mole removed from his foot during a recent checkup with a dermatologist was found to be a melanoma. (Source: NYT Health ..read more
Visit website
Military Service Can Bring Melanoma Danger
MedWorm - Melanoma News
by
3w ago
TUESDAY, March 12, 2024 — U.S. military veterans, especially those who served in the Air Force, are at high risk for one of the deadliest skin cancers, melanoma.The risk owes to work hazards associated with service in countries near the equator... (Source: Drugs.com - Daily MedNews ..read more
Visit website
Does breast radiation therapy raise risk of skin cancer?
MedWorm - Melanoma News
by
1M ago
Radiation therapy for breast cancer treatment leads to an increased risk of skin cancer, according to research published March 8 in JAMA Network Open. A team led by Shawheen Rezaei from Stanford University found that the risk of non-keratinocyte skin cancer diagnosis such as melanoma and hemangiosarcoma after breast cancer treatment with radiation was more than 50% higher. “Although occurrences of non-keratinocyte skin cancers are rare, physicians should be aware of this elevated risk to help inform follow-up care,” the Rezaei team wrote. While breast cancer treatment strategies have improved ..read more
Visit website
TIL for Melanoma: What Are the Costs and Challenges? TIL for Melanoma: What Are the Costs and Challenges?
MedWorm - Melanoma News
by
1M ago
A new FDA-approved treatment for melanoma has hit the market with a high price, and clinicians are working with insurers to determine out-of-pocket costs for patients.MDedge News (Source: Medscape Hematology-Oncology Headlines ..read more
Visit website
New NCCN Melanoma Guidelines Capture Evolving Best Practice New NCCN Melanoma Guidelines Capture Evolving Best Practice
MedWorm - Melanoma News
by
1M ago
NCCN guidelines for cutaneous melanoma, issued in February, capture evolving data for both diagnosis and treatment, diverging incrementally from 2019 AAD guidelines.Medscape Medical News (Source: Medscape Internal Medicine Headlines ..read more
Visit website
BAMF Health to partner with Corewell Health
MedWorm - Melanoma News
by
1M ago
BAMF Health and Corewell Health Haworth Innovative Therapeutics Clinic plan to collaborate on a clinical trial to test targeted radiation therapy for cancer patients. The phase I trial is sponsored by Y-mAbs Therapeutics and will include both adolescent and adult patients with recurrent or resistant small-cell lung cancer, sarcoma, and malignant melanoma. Trial participants will receive tumor-targeting treatment with an antibody that binds to a protein called GD-2 on the surface of the cancer cells, then a radioisotope infusion that binds to the antibody and delivers the radiation to cancer ce ..read more
Visit website

Follow MedWorm - Melanoma News on FeedSpot

Continue with Google
Continue with Apple
OR